Does performance-based financing of health care work?
Presentation by Bruno Meessen, from The Institute of Tropical Medicine in Belgium
Performance-based financing of health care in low- and middle-income countries- what are they and do they work?
We are happy to announce that a highly recognized expert in health sector reform, Bruno Meessen, from The Institute of Tropical Medicine in Belgium is visiting us here in Bergen. He invites you and your network to a seminar to discuss performance-based financing of health care in low- and middle-income countries- what are they and do they work?
In his presentation, he will in particular address a new critic on performance-based financing in a newly published article here;http://gh.bmj.com/content/3/1/e000664, and further discuss if and how performance-based financing can work. Meessen warmly welcome questions from students and other academics from the audience both during and after his presentation.
Join us for this exciting event!
Pastry and tea/coffee will be served.
Read/hear more about Meessen here;
Bruno Meessen is an economist (M.A., Ph.D., Université Catholique de Louvain). He heads the Health Economics Unit of the Department of Public Health, at the Institute of Tropical Medicine, Antwerp, Belgium (www.itg.be<http://www.itg.be/>). His main domain of expertise is health sector reform, health care financing, performance-based financing and pro-poor strategies in low- and middle-income countries. His current region of focus is Africa. He is the lead facilitator of the African Performance-Based Financing Community of Practice.
Also here; https://vimeo.com/88263457.
This event is based on a colaboration with the research centre; Global Health Priorities.
Global Health Priorities is situated at the Department of Global Health and primary Care at the University of Bergen. The GHP research group study the ethics and economics of priority setting in health, and the background and implications of health policies and planning. Key research topics are: the ethics of decisions at a clinical and population level, local implications of global and national health policies, equity-efficiency trade-offs, and standard and extended health economic evaluations.
Read more about GHP here; http://www.uib.no/en/rg/globpri